Skip to main content

Table 3 The most common (≥3%) treatment-emergent prefilled pen injection site-related adverse events

From: An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects

 

n

%

Number of patients who received at least 1 injection with prefilled pen

72

100

Injection site-related adverse event

   Injection site pain

5

7

   Injection site hematoma

4

6

   Injection site erythema

2

3

   Injection site hemorrhage

2

3

   Injection site induration

2

3

  1. Note: A patient was counted only once within each preferred adverse event term.